phentermine or glp-1 vs Medications: Which Weight Loss Option Is Right for You? Debunking Myths About Semaglutide &

Groundbreaking clinical trials published in late 2023 and 2024 show that semaglutide, approved in 2019 for treating diabetes and in 2021 for weight management, also reduces rates of heart disease and kidney disease, and reduces tissue and systemic inflammation

doi: 10.3389/fcell.2020.586578 37 KoppulaPLeiGZhangYYanYMaoCKondiparthiLet al

Omega Peptides Australia supplies GHK-Cu as a high-purity (99% HPLC) lyophilised powder in 50mg and 100mg vials, COA-verified on every batch and dispatched same day from within Australia

Immune system: GLP-1 receptors are found on macrophages, monocytes, and endothelial cells - key players in immune regulation and inflammatory responses